Adicet data hints at early promise for 'gamma delta' cell therapy
Bio Pharma Dive
MAY 27, 2022
Four of six lymphoma patients in a small trial went into remission, an early but encouraging sign for an emerging form of cellular immunotherapy.
Fri.May 27, 2022
169 
World Hunger Day 2022: History, Theme and Ways to Support the Movement
XTalks
MAY 27, 2022
World Hunger Day is observed each year on May 28 to raise awareness about the dramatic rise in hunger in recent years. While the day was created prior to the COVID-19 pandemic, the unprecedented global crisis has forced hundreds of millions of people into chronic hunger, escalating the need for change. Here’s everything you need to know about World Hunger Day 2022.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Gene linked to severe learning disabilities governs cell stress response
Scienmag
MAY 27, 2022
DURHAM, N.C. – A gene that has been associated with severe learning disabilities in humans has been found to also play a vital role in cells’ response to environmental stress, according to a Duke University study appearing May 24 in the journal Cell Reports. Credit: DINACHI OKONKWO, Duke University DURHAM, N.C. – A gene that […].
Akili partners with gaming giant Roblox on ADHD therapy delivery
pharmaphorum
MAY 27, 2022
Digital health company Akili Interactive has agreed a deal that could see its gamified therapy for attention-deficit hyperactivity disorder (ADHD) hosted on the creative gaming platform Roblox, used by around 55 million users worldwide. First launched in 2006, Roblox is an online space where users can play games – more than 20 million of them at a recent count – created by developers and individuals.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fastest carbon dioxide catcher heralds new age for direct air capture
Scienmag
MAY 27, 2022
Tokyo, Japan – Researchers from Tokyo Metropolitan University have developed a new carbon capture system which removes carbon dioxide directly from the atmosphere with unprecedented performance. Isophorone diamine (IPDA) in a “liquid-solid phase separation” system was found to remove carbon dioxide at the low concentrations contained in the atmosphere with 99% efficiency.
AstraZeneca kidney inflammation treatment trial reaches dosing stage
Pharma Times
MAY 27, 2022
Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Can technology help diversify clinical trials?
pharmaphorum
MAY 27, 2022
This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. You can read part one of this article here. As the shift to home working proliferated during the pandemic, work became decentralised – and many businesses were able to be productive with a workforce at home.
Social media data show language related to depression didn’t spike after initial pandemic wave
Scienmag
MAY 27, 2022
Researchers who analyzed language related to depression on social media during the pandemic say the data suggest people learned to cope as the waves wore on. Credit: John Ulan Researchers who analyzed language related to depression on social media during the pandemic say the data suggest people learned to cope as the waves wore on. […].
Thousands to potentially benefit from Roche treatment for sight loss
Pharma Times
MAY 27, 2022
Faricimab is administered as an eye injection with an interval of up to 16 weeks
No photosynthetic improvement in ictB transformants in field-grown model crop
Scienmag
MAY 27, 2022
CHAMPAIGN, Ill. — It is projected that by the year 2050, the global food supply will need to increase by 50-80% to keep up with the growing population. Researchers all over the world have been working to find ways to sustainably grow food crops to meet this need, and improving photosynthesis in plants holds great […].
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Roche trumpets new glofitamab data in lymphoma at ASCO
pharmaphorum
MAY 27, 2022
Roche will present the new data at next week’s ASCO congress showing that its bispecific antibody glofitamab can achieve high and durable responses in patients with aggressive lymphoma. The results of the phase 2 NP30179 study will be presented for the first time at ASCO, involving 107 patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who had received a median of three prior therapies.
Joint research revealed the importance of anthropogenic vapors on haze pollution over Hong Kong and Mainland China’s megacities
Scienmag
MAY 27, 2022
Prof. WANG Zhe, Assistant Professor at the Hong Kong University of Science and Technology (HKUST)’s Division of Environment and Sustainability, has collaborated with international scientists and revealed the significant roles of anthropogenic low-volatility organic vapors on the secondary organic aerosols (SOA) formation in four megacities in China, providing new insights for effectively mitigating the urban […].
FDA Efforts to Result in Millions of Additional Bottles of Infant Formula to Further Increase U.S. Supply
The Pharma Data
MAY 27, 2022
Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula on U.S. store shelves in the coming weeks and months. “We continue to work around the clock with our government partners and industry to ensure there’s adequate infant formula available wherever and whenever parents and caregivers need it,” said FDA Commissioner Robert M.
Wine as scapegoat in trade disputes means consumers pay the price
Scienmag
MAY 27, 2022
URBANA, Ill. – When you sit down for a nice dinner and sip a glass of wine, is your bottle of choice from France, Australia, or South America? Chances are the fine beverage you’re enjoying is imported from a major global wine producer. Credit: Marianne Stein, University of Illinois. URBANA, Ill. – When you sit […].
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
New patent for Astrazeneca drug SYMBICORT
Drug Patent Watch
MAY 27, 2022
Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are ten patents protecting…. The post New patent for Astrazeneca drug SYMBICORT appeared first on DrugPatentWatch - Make Better Decisions.
Watching video feed of hospitalized baby improves pumping experience
Scienmag
MAY 27, 2022
Parents who used videoconferencing technology to view their hospitalized baby reported an improved pumping experience while expressing milk for their premature infant. Videoconferencing also helped the whole family connect to their infant in the Neonatal Intensive Care Unit (NICU). These findings were published in Breastfeeding Medicine this month. Credit: UC Davis Health Parents who used […].
New patent for Antares Pharma drug TLANDO
Drug Patent Watch
MAY 27, 2022
Annual Drug Patent Expirations for TLANDO Tlando is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. The generic ingredient…. The post New patent for Antares Pharma drug TLANDO appeared first on DrugPatentWatch - Make Better Decisions.
Women resent compliments about communality at work
Scienmag
MAY 27, 2022
ITHACA, N.Y. – Women feel more frustrated than men by the gendered expectations placed on them at work, even when those expectations appear to signal women’s virtues and are seen as important for workplace advancement, according to new Cornell University research. Both women and men face gendered pressures at work. While men are expected to […].
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
New patent for Eli Lilly drug OLUMIANT
Drug Patent Watch
MAY 27, 2022
Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…. The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch - Make Better Decisions.
Comparing cancer-related spending, mortality rates in high-income countries
Scienmag
MAY 27, 2022
About The Study: Researchers found in this study of 22 high-income countries that cancer care spending in 2020 was not associated with age-standardized cancer mortality rates, and that although the United States spent more on cancer care than any other country, this expenditure was not associated with substantially lower cancer mortality rates. Authors: Cary P.
New patent for Upsher Smith drug TOSYMRA
Drug Patent Watch
MAY 27, 2022
Annual Drug Patent Expirations for TOSYMRA Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There are seven…. The post New patent for Upsher Smith drug TOSYMRA appeared first on DrugPatentWatch - Make Better Decisions.
Seeing how odor is processed in the brain
Scienmag
MAY 27, 2022
A specially created odor delivery device, along with machine learning-based analysis of scalp-recorded electroencephalogram, has enabled researchers at the University of Tokyo to see when and where odors are processed in the brain. The study found that odor information in the brain is unrelated to perception during the early stages of being processed, but when […].
Accelerating Clinical Supply Through Integrated Drug Development
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Mirati heads for FDA verdict on KRAS drug with new data
pharmaphorum
MAY 27, 2022
Mirati Therapeutics will hear from the FDA on its KRAS inhibitor adagrasib later this year, hoping to compete with first-to-market rival Lumakras from Amgen. However, new data due to be presented at ASCO suggest that could be changing. In a phase 2 trial, adagrasib achieved an overall response rate of 43% in 112 patients with non-small cell lung cancer (NSCLC) with KRAS G12C mutations who had been treated with at least one prior systemic therapy.
New light-powered catalysts could aid in manufacturing
Scienmag
MAY 27, 2022
CAMBRIDGE, MA — Chemical reactions that are driven by light offer a powerful tool for chemists who are designing new ways to manufacture pharmaceuticals and other useful compounds. Harnessing this light energy requires photoredox catalysts, which can absorb light and transfer the energy to a chemical reaction. Credit: Richard Liu CAMBRIDGE, MA — Chemical reactions […].
4th Extracellular Vesicle-Based Therapeutic Development Summit
pharmaphorum
MAY 27, 2022
Accelerating the Discovery, Translation & Large-Scale Manufacturing of Exosomes & EVs. With 3 days of unrivaled content and two dedicated tracks, this year’s summit will be putting the spotlight on cutting-edge strategies from discovery, translation, and clinical development of modified and unmodified exosomes and EVs, to accelerate this emerging field forward.
When hurricanes strike, social media can save lives
Scienmag
MAY 27, 2022
Everyone knows that while disinformation is a problem, social media is a powerful tool for communicating fast in an emergency. Credit: University of Central Florida Everyone knows that while disinformation is a problem, social media is a powerful tool for communicating fast in an emergency. In 2011 only about 10% of the U.S. population turned […].
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
13th World Multispecifics Summit
pharmaphorum
MAY 27, 2022
The 13 th Annual World Multispecific Summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field.
New insights into the complexity of the brain
Scienmag
MAY 27, 2022
A recent study out of the Complexity Science Hub (CSH) Vienna paves the way to a deeper insight into the complexity of the human brain, one of the largest and most sophisticated organs in the human body. The study – which develops a mathematical and computational framework for analysing neural activity in C. elegans, a […].
New pivotal data demonstrate clinical benefit of Roche’s glofitamab, a potential first-in-class bispecific antibody for people with aggressive lymphoma
The Pharma Data
MAY 27, 2022
Data to be presented for the first time at ASCO and EHA 2022 show glofitamab induces high and durable complete response rates in people with heavily pre-treated diffuse large B-cell lymphoma¹ Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma Glofitamab is part of Roche’s industry-leading CD20xCD3 bispecific antibody development programme, which aims to address the diverse needs and prefer
Analysis of household catastrophic health care expenditures associated with chronic disease
Scienmag
MAY 27, 2022
About The Study: Changes in catastrophic health care expenditures associated with chronic diseases in U.S. households from 2008 to 2018 were evaluated in this study. Authors: Young-Rock Hong, Ph.D., M.P.H., of the University of Florida in Gainesville, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link […].
The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Let's personalize your content